Likes
Company was not supporting in COVID-19, that's why i reisigned job, company not provide salary 1 April to 20 April that salary which government given tells to send all the employees of company
read morei
Venus Remedies
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
Sun Pharmaceutical Industries Senior Executive Regulatory Affairs Salary
6 - 12 years exp. (16 salaries) | ₹5.5 L/yr - ₹8.6 L/yr
133%
more | |
Biocon Limited Senior Executive Regulatory Affairs Salary
2 - 6 years exp. (12 salaries) | ₹4.5 L/yr - ₹7.1 L/yr
64%
more | |
Login to view exact salary
| ||
Zydus Lifesciences Senior Executive Regulatory Affairs Salary
3 - 7 years exp. (4 salaries) | ₹5.2 L/yr - ₹6.8 L/yr
91%
more | |
Lupin Senior Executive Regulatory Affairs Salary
8 - 11 years exp. (5 salaries) | ₹6.9 L/yr - ₹8.1 L/yr
143%
more | |
Micro Labs Senior Executive Regulatory Affairs Salary
5 - 7 years exp. (7 salaries) | ₹6.4 L/yr - ₹8.3 L/yr
121%
more | |
Indoco Remedies Senior Executive Regulatory Affairs Salary
7 - 11 years exp. (7 salaries) | ₹6.4 L/yr - ₹14 L/yr
226%
more | |
FDC Senior Executive Regulatory Affairs Salary
5 - 12 years exp. (4 salaries) | ₹6.3 L/yr - ₹8.5 L/yr
135%
more | |
Unichem Laboratories Senior Executive Regulatory Affairs Salary
7 - 12 years exp. (4 salaries) | ₹7.8 L/yr - ₹10.5 L/yr
191%
more | |
Shilpa Medicare Senior Executive Regulatory Affairs Salary
6 - 10 years exp. (4 salaries) | ₹6.7 L/yr - ₹8 L/yr
149%
more | |
Cadila Pharmaceuticals Senior Executive Regulatory Affairs Salary
7 - 13 years exp. (4 salaries) | ₹5 L/yr - ₹10.7 L/yr
167%
more | |
ACG Worldwide Senior Executive Regulatory Affairs Salary
5 - 22 years exp. (3 salaries) | ₹12 L/yr - ₹13 L/yr
299%
more | |
Login to view exact salary
| ||
Novo Nordisk Senior Executive Regulatory Affairs Salary
3 - 5 years exp. (3 salaries) | ₹1 L/yr - ₹15.5 L/yr
175%
more | |
Medtronic Senior Executive Regulatory Affairs Salary
6 - 9 years exp. (3 salaries) | ₹6.1 L/yr - ₹20 L/yr
320%
more | |
Discover interview dos and don'ts from real experiences
Top trending discussions